New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline.
about
Pharmacological interventions for non-ulcer dyspepsiaPharmacological interventions for non-ulcer dyspepsiaReview article: current treatment options and management of functional dyspepsiaTreatment of functional dyspepsia with serotonin agonists: a meta-analysis of randomized controlled trials.Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders.Subtypes of functional dyspepsia.Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases.Effects of itopride hydrochloride on plasma gut-regulatory peptide and stress-related hormone levels in healthy human subjects.Review article: current and emerging therapies for functional dyspepsia.Prokinetics in the Management of Functional Gastrointestinal Disorders.Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study.Thermal care of functional dyspepsia based on bicarbonate-sulphate-calcium water: a sequential clinical trial.Antidepressants in the Treatment of Functional Dyspepsia: A Systematic Review and Meta-Analysis.Drugs acting on serotonin receptors for the treatment of functional GI disorders.Gastrointestinal motility disorders: an update.Therapeutic strategies for the treatment of dyspepsia.Overlap of functional dyspepsia and GERD--diagnostic and treatment implications.Current management strategies and emerging treatments for functional dyspepsia.Review article: adherence to Rome criteria in therapeutic trials in functional dyspepsia.Visceral hypersensitivity and electromechanical dysfunction as therapeutic targets in pediatric functional dyspepsia.Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?Effects of mosapride on esophageal functions and gastroesophageal reflux.The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial.A Systematic Review of the Effectiveness of Antianxiety and Antidepressive Agents for Functional Dyspepsia.Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia.Serotonin Transporter Gene (SLC6A4) Polymorphism May Be Associated with Chinese Globus Pharyngeus and Its Antidepressant Effects.Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.Mosapride treatment for functional dyspepsia: a meta-analysis.Diagnosis and treatment of functional gastrointestinal disorders in the Asia-Pacific region: a survey of current practices.Hypothesis Driven Research and Molecular Mechanisms in Functional Dyspepsia: The Beginning of a Beautiful Friendship in Research and Practice?Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia: A Randomized, Controlled Trial
P2860
Q24234257-20FAC19F-3D08-467F-ADD0-D9EF7A2A3E50Q24244245-57C324DA-02E2-446F-9642-33E7E0A6A55FQ26825651-9BAC3048-274E-476D-9CF2-66E47D591455Q33298440-E5A4EB7F-EE2D-4FDA-B474-76CBD0AF7F20Q33682414-5851F559-B833-4060-BE9D-69082F6DBA97Q34037369-3E47FCC9-101D-406B-A120-47B529F4919BQ34318616-1804E435-71C4-40E4-99F5-818190145C35Q34529391-BF42FEE6-0DA3-45D3-A1B8-683C2CC07D8AQ34553942-BDDD3E06-E66B-4DDF-BB51-4D5BE1D3D956Q35834499-ED2BF706-AD38-4880-98A1-FFE47E9796AEQ35893549-B5902561-8B0C-4CAC-B30B-4A32ED3B0644Q35995129-5ED132BE-7F13-48FF-9B26-C04188A6563EQ36054184-1FA393AF-0C14-49E4-83CC-48541A214CFFQ36478089-4BA2ECE8-11E6-47A2-BADB-759046EA9F77Q36540251-9DA52F9F-B725-4C6D-A99A-8B36D7246697Q37781371-88B2827D-034E-4AAF-A3E0-B594DE08FF00Q38072281-4FA7CF4A-0D44-4C4A-8D44-C7C7F2E22505Q38079140-26F22ACA-6588-4E1D-BAFB-C84D66BBDAD0Q38233254-E6C2E323-5025-40F8-BFCD-B6A24E50898EQ38240885-8C2B5DA9-1604-4985-8522-CF48CBC899FBQ39278329-79F69393-1045-4356-81FA-EE0D0228F2A6Q42995641-EEB85A3D-89E7-4C8A-88F8-761A3113BBECQ46887384-87B52FFB-5872-4118-8BD5-0C3FF41B79C3Q47098199-F23EDC5D-1764-46B4-AFCC-865C3AE58626Q47283483-6740D0CF-C940-458E-B486-DEDC0DCB5445Q47647993-084D323A-DB03-4FC4-9F49-2E6F264CD9A8Q53017567-2B0386D6-F230-4856-86A9-BC6F7428A154Q53149792-F9D1FDA2-D409-46D7-BAAB-8DDC9C99D5DFQ53431573-444C237E-CB26-4BD9-B581-15E64FAE17C8Q57789593-8DFCF339-E6AD-4561-A7C7-282877C04448Q58737431-913FB274-0522-4A58-9603-6363E442A49A
P2860
New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
New strategy of therapy for fu ...... , mosapride and amitriptyline.
@ast
New strategy of therapy for fu ...... , mosapride and amitriptyline.
@en
New strategy of therapy for fu ...... , mosapride and amitriptyline.
@nl
type
label
New strategy of therapy for fu ...... , mosapride and amitriptyline.
@ast
New strategy of therapy for fu ...... , mosapride and amitriptyline.
@en
New strategy of therapy for fu ...... , mosapride and amitriptyline.
@nl
prefLabel
New strategy of therapy for fu ...... , mosapride and amitriptyline.
@ast
New strategy of therapy for fu ...... , mosapride and amitriptyline.
@en
New strategy of therapy for fu ...... , mosapride and amitriptyline.
@nl
P2093
P2860
P1476
New strategy of therapy for fu ...... , mosapride and amitriptyline.
@en
P2093
Hatakeyama N
Horikawa Y
Matsuhashi T
Odashima M
P2860
P356
10.1111/J.1365-2036.2005.02473.X
P407
P478
21 Suppl 2
P577
2005-06-01T00:00:00Z